Bayer’s long-term commitment to the consumer health market is one of the key issues facing Bill Anderson, who has been named as the German firm’s next CEO, effective from 1 June 2023.
CEO of Roche’s Pharmaceuticals division for the past four years, Anderson is set to take over from Werner Baumann, who...





